Premium
Association of the CYP3A5 A6986G ( CYP3A5*3 ) polymorphism with saquinavir pharmacokinetics
Author(s) -
Fröhlich Margit,
Hoffmann Michael M.,
Burhenne Jürgen,
Mikus Gerd,
Weiss Johanna,
Haefeli Walter E.
Publication year - 2004
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2004.02159.x
Subject(s) - saquinavir , pharmacokinetics , pharmacology , bioavailability , cyp3a , indinavir , cyp3a4 , drug metabolism , chemistry , biology , drug , metabolism , cytochrome p450 , biochemistry , immunology , virus , sida , human immunodeficiency virus (hiv) , viral disease , viral load , antiretroviral therapy